BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Collins J, Ali-ibrahim A, Smoot DT. Antibiotic Therapy for Helicobacter pylori. Medical Clinics of North America 2006;90:1125-40. [DOI: 10.1016/j.mcna.2006.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Page RL 2nd, Ferguson D, Cantu M. An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure. Cardiology 2008;110:112-5. [PMID: 17971660 DOI: 10.1159/000110489] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
2 Sánchez-sixto C, Prazeres VF, Castedo L, Suh S, Lamb H, Hawkins A, Cañada F, Jiménez-barbero J, González-bello C. Competitive Inhibitors ofHelicobacter pylori Type II Dehydroquinase: Synthesis, Biological Evaluation, and NMR Studies. ChemMedChem 2008;3:756-70. [DOI: 10.1002/cmdc.200700307] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
3 Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, Norelli F, Contorni M, Peppoloni S, Berti D, Tornese D, Ganju J, Palla E, Rappuoli R, Scharschmidt BF, Del Giudice G. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Gastroenterology. 2008;135:787-795. [PMID: 18619971 DOI: 10.1053/j.gastro.2008.05.054] [Cited by in Crossref: 114] [Cited by in F6Publishing: 99] [Article Influence: 8.1] [Reference Citation Analysis]
4 Del Giudice G, Malfertheiner P, Rappuoli R. Development of vaccines against Helicobacter pylori. Expert Rev Vaccines. 2009;8:1037-1049. [PMID: 19627186 DOI: 10.1586/erv.09.62] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
5 Sierra F, Forero JD, Rey M, Botero ML, Cárdenas A. Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication. Aliment Pharmacol Ther. 2013;37:1165-1171. [PMID: 23656465 DOI: 10.1111/apt.12329] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
6 Pourakbari B, Mahmoudi S, Parhiz J, Sadeghi R, Monajemzadeh M, Mamishi S. High frequency of metronidazole and clarithromycin-resistant Helicobacter pylori in formalin-fixed, paraffin-embedded gastric biopsies. British Journal of Biomedical Science 2018;75:61-5. [DOI: 10.1080/09674845.2017.1391466] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
7 Lin LC, Chattopadhyay S, Lin J, Hu CJ. Advances and Opportunities in Nanoparticle- and Nanomaterial-Based Vaccines against Bacterial Infections. Adv Healthcare Mater 2018;7:1701395. [DOI: 10.1002/adhm.201701395] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 9.3] [Reference Citation Analysis]